findmyKOL

Scott Solomon, MD

Enriched profile

Edward D. Frohlich Distinguished Chair; Professor of Medicine, Harvard Medical School; Director, Clinical Trials Outcomes Center; Director, Noninvasive Cardiology; Senior Physician, Brigham and Women's Hospital · Brigham and Women's Hospital

ORCIDNPI
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyCardiovascular DiseaseFocusHeart Failure Treatment and Management+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1989–2026

Scott Solomon is Edward D. Frohlich Distinguished Chair; Professor of Medicine, Harvard Medical School; Director, Clinical Trials Outcomes Center; Director, Noninvasive Cardiology; Senior Physician, Brigham and Women's Hospital at Brigham and Women's Hospital. OpenAlex indexes 2,109 publications with 187,732 citations (h-index 190); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 31 Aug 2026

Scott D. Solomon, MD, is Edward D. Frohlich Distinguished Chair at Brigham and Women's Hospital / Harvard Medical School. The public record shows 2,109 publications with 187,732 citations (h-index 190), centered on Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 24 companies, 5 NIH-funded awards (1989–2026).

  • Most recent indexed publication: 2026 · European journal of heart failure
  • Top research focus: Heart Failure Treatment and Management
  • 13 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 24 companies

Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure4 trialsLeukemia (AML/ALL/CML/CLL)3 trialsLeukemia, Myeloid, Acute3 trialsMDS / MPN2 trialsHematologic Neoplasms2 trialsHypertension1 trialCardiovascular Diseases1 trialAtherosclerosis1 trialVascular Diseases1 trialRenal Artery Obstruction1 trialHypertension, Renovascular1 trialPain1 trialNeck Pain1 trialCoronary Artery Disease / ACS1 trialMyocardial Infarction1 trialInfarction1 trialCOVID-191 trialLymphoma1 trialMultiple Myeloma1 trialPrecursor Cell Lymphoblastic Leukemia-Lymphoma1 trialLymphoma, Non-Hodgkin1 trialHodgkin Disease1 trialAutoimmune Diseases1 trialImmune System Diseases1 trialAnemia, Aplastic1 trialTic Disorders1 trialType 2 Diabetes

Research focus

OpenAlex concept fingerprint
Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Treatment and ManagementCardiac pacing and defibrillation studiesCardiac Imaging and Diagnostics

Drugs & molecules

across trials, industry payments and publications
Farxigageneric · DapagliflozinClinical trialsIndustry payments14Publications18Kerendiageneric · FinerenoneClinical trialsIndustry payments10Publications11Amvuttrageneric · VutrisiranClinical trialsIndustry payments1Publications4

Works with

trial sponsors and companies reporting payments
Boston Scientific CorporationClinical trials1Industry payments3AstraZeneca Pharmaceuticals LPClinical trialsIndustry payments28AstraZeneca UK LimitedClinical trialsIndustry payments25

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
2,109publications

Distinct works indexed by OpenAlex, matched via ORCID; 135 in PubMed.

187,732citations

Total citations across indexed works.

190h-index

Hirsch index (OpenAlex). i10-index 1,125.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials
24companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
5NIH grants · 1989–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 31 Aug 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 31 Aug 2026

24 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    65%
    Statin18.1%
    Atorvastatin Calcium71%Rosuvastatin Calcium29%
    Part D<11 patients
    Beta blocker18.1%
    Metoprolol Succinate100%
    Part D14 patients
  • Metabolism & gastrointestinal

    23.3%
    SGLT2 inhibitor23.3%
    Farxiga74%Jardiance26%
    Part D<11 patients
  • Blood & clotting

    11.7%
    Factor Xa inhibitor7.8%
    Eliquis100%
    Part D<11 patients
    P2Y12 inhibitor3.9%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 31 Aug 2026

5 NIH research awards on record, funded 19892026 per NIH RePORTER. The latest:

Congress activity

Updated 31 Aug 2026

3 congress contributions (2018–2020) across ADA per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 31 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 31 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

John J.V. McMurray842Brian Claggett731Marc A. Pfeffer397

Online presence

Updated 31 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/scott-solomon-2175ab39

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Scott-Solomon-4

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • Doximity

    doximity.com/pub/scott-solomon-md-7bd9aea7

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    hcplive.com/view/scott-solomon-from-brigham-and-womens-hospital-building-momentum-to-help-heart-failure-patients

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com
  • Other

    hcplive.com/view/the-heart-team-at-aha-2022-updates-in-heart-failure-with-scott-solomon-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 31 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Director

    Clinical Trials Outcomes Center, Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org
  • Director

    Noninvasive Cardiology, Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radcliffecardiology.com
  • Director

    Cardiac Imaging Core Laboratory (Echocore)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →echocore.com
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dinaqor.com
  • Advisor

    Cardior Pharmaceuticals

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.